Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Raedler, Thomas J
Knable, Michael B
and
Weinberger, Daniel R
1998.
Schizophrenia as a developmental disorder of the cerebral cortex.
Current Opinion in Neurobiology,
Vol. 8,
Issue. 1,
p.
157.
Waddington, John L.
Lane, Abbie
Scully, Paul J.
Larkin, Conall
and
O'Callaghan, Eadbhard
1998.
NEURODEVELOPMENTAL AND NEUROPROGRESSIVE PROCESSES IN SCHIZOPHRENIA.
Psychiatric Clinics of North America,
Vol. 21,
Issue. 1,
p.
123.
BUCKLEY, PETER F.
1998.
The Clinical Stigmata of Aberrant Neurodevelopment in Schizophrenia.
The Journal of Nervous & Mental Disease,
Vol. 186,
Issue. 2,
p.
79.
Cantor-Graae, Elizabeth
Ismail, Baher
and
McNeil, T.F
1998.
Neonatal head circumference and related indices of disturbed fetal development in schizophrenic patients.
Schizophrenia Research,
Vol. 32,
Issue. 3,
p.
191.
Ismail, Baher
Cantor-Graae, Elizabeth
and
McNeil, Thomas F.
1998.
Minor Physical Anomalies in Schizophrenic Patients and Their Siblings.
American Journal of Psychiatry,
Vol. 155,
Issue. 12,
p.
1695.
Tarrant, C Jane
and
Jones, Peter B
1999.
The Specificity of Developmental Precursors of Schizophrenia and Affective Disorders.
Psychiatric Annals,
Vol. 29,
Issue. 3,
p.
137.
Waddington, John L
Lane, Abbie
Larkin, Conall
and
O’Callaghan, Eadbhard
1999.
The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease.
Biological Psychiatry,
Vol. 46,
Issue. 1,
p.
31.
Horrobin, D.F.
and
Bennett, C.N.
1999.
New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism.
Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA),
Vol. 60,
Issue. 3,
p.
141.
Waddington, J. L.
1999.
Search for the Causes of Schizophrenia.
p.
373.
Jones, P. B.
1999.
Search for the Causes of Schizophrenia.
p.
91.
Waddington, John L
Lane, Abbie
Scully, Paul
Meagher, David
Quinn, John
Larkin, Conall
and
O’Callaghan, Eadbhard
1999.
Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to ‘neuroprogressive’ process.
Journal of Psychiatric Research,
Vol. 33,
Issue. 6,
p.
477.
Tarrant, C Jane
and
Jones, Peter B
1999.
Precursors to Schizophrenia: Do Biological Markers Have Specificity?.
The Canadian Journal of Psychiatry,
Vol. 44,
Issue. 4,
p.
335.
Preti, Antonio
Cardascia, Lucia
Zen, Tiziana
Marchetti, Maria
Favaretto, Gerardo
and
Miotto, Paola
2000.
Risk for obstetric complications and schizophrenia.
Psychiatry Research,
Vol. 96,
Issue. 2,
p.
127.
Fannon, Dominic
Tennakoon, Lakshika
Sumich, Alex
O'Ceallaigh, Seamus
Doku, Victor
Chitnis, Xavier
Lowe, Jennifer
Soni, William
and
Sharma, Tonmoy
2000.
Third ventricle enlargement and developmental delay in first-episode psychosis: preliminary findings.
British Journal of Psychiatry,
Vol. 177,
Issue. 4,
p.
354.
McNeil, Thomas F.
and
Cantor-Graae, Elizabeth
2000.
Minor physical anomalies and obstetric complications in schizophrenia.
Australian and New Zealand Journal of Psychiatry,
Vol. 34,
Issue. (Suppl.),
p.
S65.
Jablensky, A.
2000.
Psychiatrie der Gegenwart 5.
p.
3.
McGorry, Patrick D.
2000.
The Nature of Schizophrenia: Signposts to Prevention.
Australian & New Zealand Journal of Psychiatry,
Vol. 34,
Issue. 2_suppl,
p.
S14.
McNeil, Thomas F.
and
Cantor-Graae, Elizabeth
2000.
Minor Physical Anomalies and Obstetric Complications in Schizophrenia.
Australian & New Zealand Journal of Psychiatry,
Vol. 34,
Issue. 1_suppl,
p.
A65.
Byrne, Majella
Browne, Roy
Mulryan, Niamh
Scully, Ann
Morris, Mary
Kinsella, Anthony
Takei, Noriyoshi
McNeil, Tom
Walsh, Dermot
and
O'Callaghan, Eadbhard
2000.
Labour and delivery complications and schizophrenia.
British Journal of Psychiatry,
Vol. 176,
Issue. 6,
p.
531.
Quinn, John
Moran, Maria
Lane, Abbie
Kinsella, Anthony
and
Waddington, John L
2000.
Long-term adaptive life functioning in relation to initiation of treatment with antipsychotics over the lifetime trajectory of schizophrenia.
Biological Psychiatry,
Vol. 48,
Issue. 2,
p.
163.